Investor Backlash and Market Pressures Challenge CoreWeave’s Core Scientific Acquisition
CoreWeave's proposed acquisition of Core Scientific faces mounting opposition, with key shareholders publicly rejecting the deal. Two Seas Capital released a presentation titled 'A Flawed Process, a Deficient Structure and an Inadequate Price,' while third-largest investor Gullane Capital plans to vote against the merger.
The $CRWV stock has declined 27% since late June amid multiple headwinds. Concerns include elevated debt-to-equity ratios, post-IPO lockup expirations triggering sell-offs, and disappointing Q2 2025 earnings. Despite this, prominent investor Harsh Chauhan remains bullish, calling the dip 'a screaming buy' for those betting on AI infrastructure growth.